Skip to content

Observation on the clinical effect of intradermal injection of SVF-gel in preventing surgical scar

Observation on the clinical effect of intradermal injection of SVF-gel in preventing surgical scar

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033683
Enrollment
Unknown
Registered
2020-06-09
Start date
2020-06-09
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cicatrix

Interventions

experimental side:SVF-gel
control side:physiological saline solution

Sponsors

Department of Plastic Surgery, the First Affiliated Hospital of Air Force Military Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients who underwent hypertrophic breast reduction surgery; 2. Female patients aged 18-60 years; 3. Four postoperative follow-up points were intact (7 days, 1 month, 3 months, and 6 months postoperation). 4. The participants had proper compliance, took the test voluntarily and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. History of keloid or hypertrophic scar; 2. Allergic constitution; 3. Basic diseases affecting wound healing; 4. Breast hyperplasia or abnormal mass is not suitable for fat graft; 5. Using hormones or chemotherapeutic drugs; 6. Unable to be treated on time and failed to cooperate; 7. There are diseases that affect the results of the test.

Design outcomes

Primary

MeasureTime frame
Vancouver Scar Scale;

Secondary

MeasureTime frame
Visual analogue scale;

Countries

China

Contacts

Public ContactYi Chenggang

The First Affiliated Hospital of Air Force Military Medical University

yichg@163.com+86 13319234501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026